KRAS and pachyonychia congenita: Non-invasive diagnostic approaches hold promise for more efficient cancer surveillance, including liquid biopsy technologies targeting KRAS mutations, exosome markers, and VOC breath analysis for efficient pancreatic cancer (PC) detection.